{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:20:22Z","timestamp":1795148422383,"version":"4.10.3"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,21]]},"DOI":"10.1093\/eurheartj\/ehx163","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T16:12:19Z","timestamp":1489507939000},"page":"2478-2486","source":"Crossref","is-referenced-by-count":680,"title":["Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies"],"prefix":"10.1093","volume":"38","author":[{"given":"Christian M.","family":"Madsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Varbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,4,12]]},"reference":[{"key":"key\n\t\t\t\t20171103083513_ehx163-B1","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Emerging Risk Factors Collaboration","year":"2009","journal-title":"Jama"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.ATV.8.6.737","article-title":"High density lipoprotein cholesterol and mortality. The Framingham Heart Study","volume":"8","year":"1988","journal-title":"Arteriosclerosis"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B3","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJM199006143222403","article-title":"Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease","volume":"322","year":"1990","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B4","doi-asserted-by":"crossref","first-page":"g4379.","DOI":"10.1136\/bmj.g4379","article-title":"Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients","volume":"349","year":"2014","journal-title":"Bmj"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B5","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B6","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/01.CIR.101.16.1907","article-title":"Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene","volume":"101","year":"2000","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B7","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/S0735-1097(03)00407-8","article-title":"Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study","volume":"41","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/ATVBAHA.107.153858","article-title":"Genetic variation in ABCA1 predicts ischemic heart disease in the general population","volume":"28","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B9","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.jacc.2012.07.045","article-title":"Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects","volume":"60","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B10","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Consortium CHDE, Consortium CAE, Global Lipids Genetics C","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B11","doi-asserted-by":"crossref","first-page":"e000519.","DOI":"10.1161\/JAHA.113.000519","article-title":"Coronary heart disease risks associated with high levels of HDL cholesterol","volume":"3","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B13","doi-asserted-by":"crossref","first-page":"e1001212.","DOI":"10.1371\/journal.pmed.1001212","article-title":"The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach","volume":"9","year":"2012","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B14","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1001\/jama.2016.4666","article-title":"Change in body mass index associated with lowest mortality in Denmark, 1976-2013","volume":"315","year":"2016","journal-title":"Jama"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B15","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","article-title":". Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine","volume":"37","author":"European Atherosclerosis Society, the European Federation of Clinical Chemistry, Laboratory Medicine joint consensus initiative","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","article-title":"Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies","volume":"150","year":"1999","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","year":"2007","journal-title":"Jama"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B19","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1161\/ATVBAHA.113.301505","article-title":"Evidence of a polygenic origin of extreme high-density lipoprotein cholesterol levels","volume":"33","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B20","volume-title":"Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks","author":"World Health Organization","year":"2009"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B21","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2016.08.038","article-title":"High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions. The CANHEART Study","volume":"68","year":"2016","journal-title":". J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.2215\/CJN.00730116","article-title":"High density lipoprotein cholesterol and the risk of all-cause mortality among U.S. veterans","volume":"11","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B23","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Authors\/Task Force M","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171103083513_ehx163-B24","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(07)61813-3","article-title":"Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies","volume":"370","year":"2007","journal-title":"Lancet"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/38\/32\/2478\/21528559\/ehx163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T14:35:23Z","timestamp":1568903723000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/eurheartj\/article\/38\/32\/2478\/3608700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,12]]},"references-count":24,"journal-issue":{"issue":"32","published-online":{"date-parts":[[2017,4,12]]},"published-print":{"date-parts":[[2017,8,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehx163","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8,21]]},"published":{"date-parts":[[2017,4,12]]}}}